These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 33563314

  • 1. Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis.
    Lu H, Zheng G, Gao X, Chen C, Zhou M, Zhang L.
    J Ovarian Res; 2021 Feb 09; 14(1):30. PubMed ID: 33563314
    [Abstract] [Full Text] [Related]

  • 2. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
    Zhang C, Li Y, Zhao W, Liu G, Yang Q.
    Cancer Med; 2020 May 09; 9(10):3500-3521. PubMed ID: 32167655
    [Abstract] [Full Text] [Related]

  • 3. Propofol Represses Cell Growth and Metastasis by Modulating the Circular RNA Non-SMC Condensin I Complex Subunit G/MicroRNA-200a-3p/RAB5A Axis in Glioma.
    Zhang L, Chen H, Tian C, Zheng D.
    World Neurosurg; 2021 Sep 09; 153():e46-e58. PubMed ID: 34129971
    [Abstract] [Full Text] [Related]

  • 4. Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis.
    Sun S, Fang H.
    J Ovarian Res; 2021 Nov 16; 14(1):158. PubMed ID: 34784955
    [Abstract] [Full Text] [Related]

  • 5. Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA‑374a/forkhead box O1 signaling axis.
    Sun Y, Peng YB, Ye LL, Ma LX, Zou MY, Cheng ZG.
    Mol Med Rep; 2020 Mar 16; 21(3):1471-1480. PubMed ID: 32016462
    [Abstract] [Full Text] [Related]

  • 6. CircEXOC6B Suppresses the Proliferation and Motility and Sensitizes Ovarian Cancer Cells to Paclitaxel Through miR-376c-3p/FOXO3 Axis.
    Zheng Y, Li Z, Yang S, Wang Y, Luan Z.
    Cancer Biother Radiopharm; 2022 Nov 16; 37(9):802-814. PubMed ID: 33006481
    [Abstract] [Full Text] [Related]

  • 7. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D, Xing N, Yang T, Liu J, Zhao H, He J, Ai Y, Yang J.
    Cancer Med; 2020 Oct 16; 9(19):7218-7230. PubMed ID: 32767662
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Circ_MUC16 attenuates the effects of Propofol to promote the aggressive behaviors of ovarian cancer by mediating the miR-1182/S100B signaling pathway.
    Yang H, Guo Y, Zhang Y, Wang D, Zhang G, Hou J, Yang J.
    BMC Anesthesiol; 2021 Nov 27; 21(1):297. PubMed ID: 34837947
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Expression and significance of MAPK/ERK in the specimens and cells of epithelial ovarian cancer].
    Jiang XL, Gao JC, Jiang L, Zhang PX, Kang TJ, Sun Q, Qi WJ, Zhang QP, Guan HW, Shi H.
    Zhonghua Fu Chan Ke Za Zhi; 2019 Aug 25; 54(8):541-547. PubMed ID: 31461811
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Propofol disrupts cell carcinogenesis and aerobic glycolysis by regulating circTADA2A/miR-455-3p/FOXM1 axis in lung cancer.
    Zhao H, Wei H, He J, Wang D, Li W, Wang Y, Ai Y, Yang J.
    Cell Cycle; 2020 Oct 25; 19(19):2538-2552. PubMed ID: 32857667
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.